FreeTrader
عضو محترف
vrtx ما ادري عن الشرعيه
6/30/2006 8:20:38 AM Vertex Pharmaceuticals (VRTX) announced Friday morning that it will collaborate with Janssen Pharmaceutica to develop and commercialize VX-950, Vertex's investigational hepatitis C virus protease inhibitor. Janssen will have exclusive rights in Europe, South America, the Middle East, Africa and Australia. Vertex will retain exclusive commercial rights to VX-950 in North America.
6/30/2006 8:20:38 AM Vertex Pharmaceuticals (VRTX) announced Friday morning that it will collaborate with Janssen Pharmaceutica to develop and commercialize VX-950, Vertex's investigational hepatitis C virus protease inhibitor. Janssen will have exclusive rights in Europe, South America, the Middle East, Africa and Australia. Vertex will retain exclusive commercial rights to VX-950 in North America.